Elsa Arbajian
- Rheumatology top 5%
- Soft tissue tumor case studies 4
- Bone Tumor Diagnosis and Treatments 3
-
- Sarcoma Diagnosis and Treatment 10
- Oral Surgery top 10%
-
- Vascular Tumors and Angiosarcomas 3
-
- Epigenetics and DNA Methylation 3
-
- Neuroendocrine Tumor Research Advances 2
-
- Cardiac tumors and thrombi 2
-
- MicroRNA in disease regulation 2
- Co-authors
- Fredrik MertensLinda MagnussonFlorian PulsVaiyapuri P. SumathiJenny NilssonJakob HofvanderLars‐Gunnar KindblomKarolin H. Nord
- Journals
- The American Journal of Surgical Pathology (3 papers)Modern Pathology (2 papers)Histopathology (2 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Elsa Arbajian
18 papers receiving 523 citations
Peers
Comparison fields: 5 of 37
- Rheumatology 280
- Pulmonary and Respiratory Medicine 387
- Oral Surgery 54
- Oncology 154
- Pathology and Forensic Medicine 96
Countries citing papers authored by Elsa Arbajian
This map shows the geographic impact of Elsa Arbajian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Arbajian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Arbajian more than expected).
Fields of papers citing papers by Elsa Arbajian
This network shows the impact of papers produced by Elsa Arbajian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Arbajian. The network helps show where Elsa Arbajian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elsa Arbajian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 7 | |
| 4 | 2023 | 3 | |
| 5 | 2020 | 4 | |
| 6 | 2020 | 20 | |
| 7 | 2020 | 58 | |
| 8 | 2019 | 14 | |
| 9 | 2019 | 21 | |
| 10 | 2018 | 48 | |
| 11 | 2017 | 65 | |
| 12 | 2017 | 36 | |
| 13 | 2017 | 35 | |
| 14 | 2017 | 14 | |
| 15 | 2017 | 18 | |
| 16 | 2014 | 106 | |
| 17 | 2014 | 24 | |
| 18 | 2013 | 24 | |
| 19 | 2013 | 27 |
About Elsa Arbajian
Elsa Arbajian is a scholar working on Rheumatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 525 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (10 papers), Soft tissue tumor case studies (4 papers), Vascular Tumors and Angiosarcomas (3 papers), Epigenetics and DNA Methylation (3 papers), Bone Tumor Diagnosis and Treatments (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Cardiac tumors and thrombi (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Rheumatology (280 citations), Pulmonary and Respiratory Medicine (387 citations) and Oral Surgery (54 citations). Elsa Arbajian has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Fredrik Mertens, Linda Magnusson, Florian Puls, Vaiyapuri P. Sumathi, Jenny Nilsson, Jakob Hofvander, Lars‐Gunnar Kindblom, Karolin H. Nord, Fredrik Vult von Steyern and Cyril Fisher. Their work appears in journals such as The American Journal of Surgical Pathology, Modern Pathology, Histopathology, Genes Chromosomes and Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.